These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23723457)

  • 1. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial.
    South East Asia Infectious Disease Clinical Research Network
    BMJ; 2013 May; 346():f3039. PubMed ID: 23723457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.
    Lackenby A; Elliot AJ; Powers C; Andrews N; Ellis J; Bermingham A; Thompson C; Galiano M; Large S; Durnall H; Fleming D; Smith G; Zambon M
    J Antimicrob Chemother; 2013 Oct; 68(10):2324-31. PubMed ID: 23759670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.
    Sugaya N; Ohashi Y
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2575-82. PubMed ID: 20368393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial.
    Marty FM; Vidal-Puigserver J; Clark C; Gupta SK; Merino E; Garot D; Chapman MJ; Jacobs F; Rodriguez-Noriega E; Husa P; Shortino D; Watson HA; Yates PJ; Peppercorn AF
    Lancet Respir Med; 2017 Feb; 5(2):135-146. PubMed ID: 28094141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.
    Lee N; Hui DS; Zuo Z; Ngai KL; Lui GC; Wo SK; Tam WW; Chan MC; Wong BC; Wong RY; Choi KW; Sin WW; Lee EL; Tomlinson B; Hayden FG; Chan PK
    Clin Infect Dis; 2013 Dec; 57(11):1511-9. PubMed ID: 24046309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
    Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
    J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
    Beigel JH; Bao Y; Beeler J; Manosuthi W; Slandzicki A; Dar SM; Panuto J; Beasley RL; Perez-Patrigeon S; Suwanpimolkul G; Losso MH; McClure N; Bozzolo DR; Myers C; Holley HP; Hoopes J; Lane HC; Hughes MD; Davey RT;
    Lancet Infect Dis; 2017 Dec; 17(12):1255-1265. PubMed ID: 28958678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
    Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
    JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children.
    Oo C; Barrett J; Hill G; Mann J; Dorr A; Dutkowski R; Ward P
    Paediatr Drugs; 2001; 3(3):229-36. PubMed ID: 11310719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
    Davey RT; Fernández-Cruz E; Markowitz N; Pett S; Babiker AG; Wentworth D; Khurana S; Engen N; Gordin F; Jain MK; Kan V; Polizzotto MN; Riska P; Ruxrungtham K; Temesgen Z; Lundgren J; Beigel JH; Lane HC; Neaton JD;
    Lancet Respir Med; 2019 Nov; 7(11):951-963. PubMed ID: 31582358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
    Duval X; van der Werf S; Blanchon T; Mosnier A; Bouscambert-Duchamp M; Tibi A; Enouf V; Charlois-Ou C; Vincent C; Andreoletti L; Tubach F; Lina B; Mentré F; Leport C;
    PLoS Med; 2010 Nov; 7(11):e1000362. PubMed ID: 21072246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.
    Dawood FS; Jara J; Gonzalez R; Castillo JM; De León T; Estripeaut D; Luciani K; Sujey Brizuela Y; Barahona A; Cazares RA; Lawson AM; Rodriguez M; de Viana D; Franco D; Castillo M; Fry AM; Gubareva L; Tamura D; Hughes M; Gargiullo P; Clara W; Azziz-Baumgartner E; Widdowson MA
    Antiviral Res; 2016 Sep; 133():85-94. PubMed ID: 27451343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    Anderson KB; Simasathien S; Watanaveeradej V; Weg AL; Ellison DW; Suwanpakdee D; Klungthong C; Phonpakobsin T; Kerdpanich P; Phiboonbanakit D; Gibbons RV; Fernandez S; Macareo LR; Yoon IK; Jarman RG
    PLoS One; 2018; 13(3):e0193050. PubMed ID: 29513698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early administration of oral oseltamivir increases the benefits of influenza treatment.
    Aoki FY; Macleod MD; Paggiaro P; Carewicz O; El Sawy A; Wat C; Griffiths M; Waalberg E; Ward P;
    J Antimicrob Chemother; 2003 Jan; 51(1):123-9. PubMed ID: 12493796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of standard versus double dose oseltamivir for treating influenza in the community.
    Dixit R; Khandaker G; Hay P; McPhie K; Taylor J; Rashid H; Heron L; Dwyer D; Booy R
    Antivir Ther; 2015; 20(7):689-98. PubMed ID: 24912485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.
    Hoang Vu MP; Nguyen CT; Nguyen le KH; Nguyen TK; Le QM
    Western Pac Surveill Response J; 2013; 4(2):25-9. PubMed ID: 24015368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.